[Changes in the diagnostic and treatment strategies of patients with hematological diseases during the COVID-19 pandemic with reference to recommendations from American Society of Hematology and European Hematology Association].

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Author(s): Mori SI;Mori SI
  • Source:
    [Rinsho ketsueki] The Japanese journal of clinical hematology [Rinsho Ketsueki] 2021; Vol. 62 (2), pp. 101-105.
  • Publication Type:
    Journal Article; Review
  • Language:
    Japanese
  • Additional Information
    • Source:
      Publisher: Japan Society Of Clinical Hematology Country of Publication: Japan NLM ID: 2984782R Publication Model: Print Cited Medium: Print ISSN: 0485-1439 (Print) Linking ISSN: 04851439 NLM ISO Abbreviation: Rinsho Ketsueki Subsets: MEDLINE
    • Publication Information:
      Publication: Tokyo : Japan Society Of Clinical Hematology
      Original Publication: Tokyo, Rinsho Ketsueki Kondankai.
    • Subject Terms:
      COVID-19* ; Hematologic Diseases*/diagnosis ; Hematologic Diseases*/epidemiology ; Hematologic Diseases*/therapy ; Hematology*; Humans ; Pandemics ; SARS-CoV-2 ; United States
    • Abstract:
      The novel coronavirus (COVID-19) pandemic has affected all aspects of human life worldwide. Under this situation, the American Society of Hematology and European Hematology Association have provided resources and recommendations for the management of hematologic diseases during the COVID-19 pandemic. This review aims to summarize these recommendations and provide helpful, accurate, and up-to-date information for Japanese hematologists.
    • Contributed Indexing:
      Keywords: COVID-19; Hematologic diseases; Practice guideline; SARS-CoV-2
    • Publication Date:
      Date Created: 20210308 Date Completed: 20210310 Latest Revision: 20210310
    • Publication Date:
      20250114
    • Accession Number:
      10.11406/rinketsu.62.101
    • Accession Number:
      33678768